Novartis Bioventures Ltd sold $748K of Aeglea Biotherapeutics, Inc.

10% owner

Sold$748,140

$10.12Price

73,955Shares

−3%Stake

What AGLE did after the filing

Prices for AGLE after this filing aren't in yet.

Traded Wed, May 9. Filed Fri, May 11, 12:28 PM ET, during the session. Not investment advice.